뉴스

The Unexpected Victim Of America’s Ozempic Boom

Retailers are reporting a disturbing new trend affecting their bottom line, and they strongly suspect it has something to do with customers using GLP-1 drugs. According to the Wall Street Journal, businesses are noticing a higher return rate, which is being chalked up to people losing weight and needing to purchase smaller sizes. The number ...

Women on Ozempic-like drugs are 30% less likely to develop breast cancer: study

A study from the University of Pennsylvania School of Medicine found more evidence that weight loss drugs could be cancer prevention tools.

‘Losing weight week over week’ — Why thousands turn to this $25 GLP-1-alternative

People are turning to “nature’s Ozempic” for weight loss — here’s why.

What’s Behind Tilman Fertitta’s $18 Billion Bet On Caesars Entertainment

Despite challenges from prediction markets, Ozempic and rising costs, the restaurateur owner of the Houston Rockets seeks to add 50 locations, and a mountain of debt, to his existing empire.

What Ozempic is actually doing to obesity rates in the US

As GLP-1 medications continue to evolve and become more popular, they're having both a major moment and impact in the health landscape.

Ozempic May Be Reshaping the Brain, Scientists Say

Co-Pays For GLP-1 Weight Loss Drugs To Rise If They’re Even Covered

GLP-1 weight loss drugs like Ozempic, Zepbound and Wegovy are the biggest contributor to rising prescription spending. And that will trigger co-payments to rise.

Move Over, Ozempic. There’s A New Weight Loss Shot Everyone Is Freaking Out About

Move over, Ozempic. There’s a new weight loss shot everyone’s freaking out about. A new experimental weight loss drug called “retatrutide” is suddenly blowing up online after clinical trial results showed patients losing an average of more than 70 pounds, with some people dropping nearly a third of their body weight. Yes, you read that right. ...

Is the End of the Obesity Epidemic Near?

Eli Lilly's retatrutide is a significant advance on the promising results from drugs like Ozempic and Wegovy.